Inflammation synergizes with a cell’s intrinsic genetic program to promote the development of pancreatic cancer.

Men are more susceptible to progressive kidney disease than women; new VUMC studies point to differences in the expression and activation of the EGF receptor.

Vanderbilt investigators have characterized how a new first-in-class antibacterial drug works, which will guide the development of additional compounds that overcome antibacterial resistance.

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.

Using gene transfer technologies to reprogram adult human kidney cells could lead to novel therapies for chronic kidney disease.

The protein kinase STK17A plays a novel role in epithelial cells and its loss may contribute to colorectal cancer invasion and metastasis, Vanderbilt researchers report.

Understanding how a bacterial protein that influences the risk of stomach cancer is produced could guide new strategies for treatment.